| Literature DB >> 31733278 |
Chao Zhong1, Sanhu Gou2, Tianqi Liu3, Yuewen Zhu3, Ningyi Zhu3, Hui Liu3, Yun Zhang3, Junqiu Xie2, Xiaomin Guo2, Jingman Ni4.
Abstract
Antimicrobial peptides have recently attracted much attention due to their broad-spectrum antimicrobial activity, rapid microbial effects, and minimal tendency toward resistance development. In this study, a series of new C-C terminals and C-N terminals dimer peptides were designed and synthesized by intermolecular dimerization of the partial d-amino acid substitution analogues of Anoplin, and the effects of different dimerization positions on biological activity were researched. The antimicrobial activity and stability of the new C-C terminals and C-N terminals dimer peptides were significantly improved compared with their parent peptide Anoplin. They displayed no obvious hemolytic activity and lower cytotoxicity, with a higher therapeutic index. Furthermore, the new dimer peptides not only enabled to rapidly disrupt bacterial membrane and damage its integrity which was different from conventional antibiotics but also penetrated bacterial membrane into binding to intracellular genomic DNA. More importantly, the new dimer peptides showed excellent antimicrobial activity against multidrug-resistant strains isolated from clinics in contrast to conventional antibiotics with low tendency to develop the bacterial resistance, besides they exhibited better anti-biofilm activity than antibiotic Rifampicin. Interestingly, the C-N terminals dimer peptides were superior to C-C terminals ones in antimicrobial and anti-biofilm activity, therapeutic index, outer membrane permeability, and DNA binding ability, whereas there were no noteworthy effects in different dimerization positions on stability. Thus, these data suggested that dimerization in different positions represented a potent strategy to develop novel antimicrobial agents for fighting against increasing bacterial resistance.Entities:
Keywords: Anoplin; Biological activity; Different dimerization positions; Dimer antimicrobial peptides; Multidrug-resistant bacteria
Year: 2019 PMID: 31733278 DOI: 10.1016/j.micpath.2019.103871
Source DB: PubMed Journal: Microb Pathog ISSN: 0882-4010 Impact factor: 3.738